ArticlePloS one2017

Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.

Eric C Sorenson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.